skip to main content

H.R. 2379: State Opioid Response Grant Authorization Act of 2021

Call or Write Congress

To amend the 21st Century Cures Act to reauthorize and expand a grant program for State response to the opioid use disorders crisis, and for other purposes.

The bill’s titles are written by its sponsor.

The federal budget process occurs in two stages: appropriations and authorizations. This is an authorization bill, which directs how federal funds should or should not be used. (It does not set overall spending limits, however, which are the subject of appropriations bills.) Authorizations are typically made for single fiscal years (October 1 through September 30 of the next year) but are often renewed in subsequent law.

Sponsor and status

David Trone

Sponsor. Representative for Maryland's 6th congressional district. Democrat.

Read Text »
Last Updated: Oct 21, 2021
Length: 11 pages
Introduced
Apr 8, 2021
117th Congress (2021–2023)
Status

Passed House (Senate next) on Oct 20, 2021

This bill passed in the House on October 20, 2021 and goes to the Senate next for consideration.

Other activity may have occurred on another bill with identical or similar provisions.

Cosponsors

8 Cosponsors (5 Republicans, 3 Democrats)

Prognosis
4% chance of being enacted according to Skopos Labs (details)
Source

Position statements

What legislators are saying

Cicilline: State Opioid Response Funding Saves Lives
    — Rep. David Cicilline [D-RI1] on Oct 21, 2021

Washington Review: October 22, 2021
    — Rep. Albio Sires [D-NJ8] on Oct 22, 2021

Higgins Announces Approval of Legislation Delivering Federal Funding to Help States Tackle Opioid Crisis
    — Rep. Brian Higgins [D-NY26] on Oct 21, 2021

More statements at ProPublica Represent...

What stakeholders are saying

R Street Institute SpendingTracker.org estimates new spending due to H.R. 2379 will be negligible.

History

Apr 8, 2021
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Jul 15, 2021
 
Considered by Health

A committee held a hearing or business meeting about the bill.

Jul 21, 2021
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Oct 15, 2021
 
Text Published

Updated bill text was published as of Preprint (Suspension).

Oct 19, 2021
 
Reported by House Committee on Energy and Commerce

A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.

Oct 20, 2021
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next.

If this bill has further action, the following steps may occur next:
 
Passed Senate

 
Signed by the President

H.R. 2379 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 2379. This is the one from the 117th Congress.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2379 — 117th Congress: State Opioid Response Grant Authorization Act of 2021.” www.GovTrack.us. 2021. December 1, 2021 <https://www.govtrack.us/congress/bills/117/hr2379>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.